A Career Journey to a Universal Definition of Heart Failure and Updates in the Management of Heart Failure

This lecture is a part of the Physician-Scientists in Medicine Series. In this presentation, Dr. Biykem Bozurt discusses her career path as a cardiologist and a heart failure researcher. She shares her insights into working as a physician-scientist and provides current updates in definitions and treatments for heart failure.

This Department of Medicine Grand Rounds session took place on Thursday, April 15, 2021 at 12:15 P.M.

CME Information

CME Credit Available

You may claim CME credit after watching this activity.

You will be redirected to an outside site when claiming credit and may be asked to register or log in.

Needs Statement

Physicians, residents, fellows, medical students and other healthcare providers across practice areas encounter health care equity issues such as health disparities,social determinants of health, cultural/linguistic competencies, and social justice. The series aims to broaden the awareness of learners in these topic areas provide strategies to address these issues as they arise.

Objectives

At the conclusion of this activity, the participant should be able to:

  • Apply the criteria for the new universal definition of heart failure.
  • Identify the revised stages of heart failure.
  • Employ the new ejection fraction classifications to heart failure.

Target Audience

  • Physicians
  • Medical Students
  • Fellows
  • Residents
  • Nurses
  • Other Health Professionals

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Director

  1. Richard J. Hamill, M.D.

    Richard J. Hamill, M.D.

    Professor
    Baylor College of Medicine

Term of Approval

April 1, 2021 through April 30, 2023. Original release date: April 1, 2021.

Disclosure Policy

The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial SupportSM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.

Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.

If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Biykem Bozkurt, M.D., Ph.D.

    Biykem Bozkurt, M.D., Ph.D.

    Professor
    Baylor College of Medicine

    Disclosure:
    • Research Support: Abbott Vascular; Anthem; Guide; LivaNova
    • Advisory Committee Membership: Amgen; Respicardia; scPharmaceuticals

Program Director

  1. Richard J. Hamill, M.D.

    Richard J. Hamill, M.D.

    Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Planning Committee Members

  1. Richard J. Hamill, M.D.

    Richard J. Hamill, M.D.

    Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Erica Lescinskas, M.D.

    Erica Lescinskas, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. Zaven Sargsayan, M.D.

    Zaven Sargsayan, M.D.

    Assistant Professor
    Baylor College of Medicine and Ben Taub Hospital

    Disclosure:

    Nothing to disclose.

  4. Chirayu Shah, M.D., M.Ed.

    Chirayu Shah, M.D., M.Ed.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  5. Stephanie Sherman, M.D.

    Stephanie Sherman, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  6. Jefferson Triozzi, M.D. Placeholder Image

    Jefferson Triozzi, M.D.

    Internal Medicine Resident
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Contributor

  1. Biykem Bozkurt, M.D., Ph.D.

    Biykem Bozkurt, M.D., Ph.D.

    Professor
    Baylor College of Medicine

    Disclosure:
    • Research Support: Abbott Vascular; Anthem; Guide; LivaNova
    • Advisory Committee Membership: Amgen; Respicardia; scPharmaceuticals

CME Credit Available

You may claim CME credit after watching this activity.

View the CME Information Claim CME

You will be redirected to an outside site when claiming credit and may be asked to register or log in.

Presenter:

  1. Biykem Bozkurt, M.D., Ph.D.

    Biykem Bozkurt, M.D., Ph.D.

    Professor Baylor College of Medicine